Weight Loss

Setmelanotide led to significant reductions in weight among people with obesity and the genetic disorder Bardet-Biedl syndrome, but not Alström syndrome, according to findings published in The Lancet Diabetes & Endocrinology.

Weight loss reduced hedonic hunger independently of modality, and bariatric surgery resulted in several beneficial changes in food reward and preferences, according to trial data published in Obesity.

SAN DIEGO — Exercising at a consistent time may encourage adults with obesity to participate in regular moderate to vigorous physical activity, according to a speaker at ObesityWeek 2022.

SAN DIEGO — Weight loss can be achieved by people who exercise in either the morning or the evening, though findings on whether morning or evening physical activity is better for losing weight are mixed, according to a speaker.

Findings from the STEP TEENS phase 3a trial showed that adolescents with obesity who received Wegovy had a significant decrease in BMI compared with those who received placebo.

SAN DIEGO — A multidisciplinary phenotype-tailored lifestyle intervention resulted in greater weight loss among adults with obesity compared with standard weight-loss interventions, according to a study presented at ObesityWeek.

SAN DIEGO — Weight loss through caloric restriction can improve cardiometabolic risk, chronic conditions and physical function for older adults with obesity, but certain factors should be considered when designing an intervention.

SAN DIEGO — For individuals, a change in depressive symptoms was associated with change in body weight, and the association was stronger for those with overweight or obesity than those with a normal BMI, according to study data.

Adults with obesity who attended virtual pharmacotherapy visits had a similar weight loss compared with those who attended in-person visits, according to study presented here.

SAN DIEGO — A weekly glucagon/GLP-1 dual receptor agonist conferred greater weight loss than 1 mg semaglutide at 16 weeks among adults with type 2 diabetes, according to findings from a phase 2 trial.